Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor.
Sequence analysis of the class A G protein-coupled receptors (GPCRs) reveals that most of the highly conserved sites are located in the transmembrane helices. A second level of conservation exists involving those residues that are conserved as a group characterized by small and/or weakly polar side chains (Ala, Gly, Ser, Cys, Thr). These positions can have group conservation levels of up to 99% across the class A GPCRs and have been implicated in mediating helix-helix interactions in membrane proteins. We have previously shown that mutation of group-conserved residues present on transmembrane helices H2-H4 in the β(2)-adrenergic receptor (β(2)-AR) can influence both receptor expression and function. We now target the group-conserved sites, Gly315(7.42) and Ser319(7.46), on H7 for structure-function analysis. Replacing Ser319(7.46) with smaller amino acids (Ala or Gly) did not influence the ability of the mutant receptors to bind to the antagonist dihydroalprenolol (DHA) but resulted in ~15-20% agonist-independent activity. Replacement of Ser319(7.46) with the larger amino acid leucine lowered the expression of the S319L mutant and its ability to bind DHA. Both the G315A and G315S mutants also exhibited agonist-independent signaling, while the G315L mutant did not show specific binding to DHA. These data indicate that Gly315(7.42) and Ser319(7.46) are stabilizing β(2)-AR in an inactive conformation. We discuss our results in the context of van der Waals interactions of Gly315(7.42) with Trp286(6.48) and hydrogen bonding interactions of Ser319(7.46) with amino acids on H1-H2-H7 and with structural water.
Department of Oral Biology, University of Manitoba, Winnipeg, MB R3E 0W4, Canada.
Makoto
M
Arakawa
Raja
R
Chakraborty
Jasbir
J
Upadhyaya
Markus
M
Eilers
Philip J
PJ
Reeves
Steven O
SO
Smith
Prashen
P
Chelikani
D000318:Adrenergic beta-Agonists / Q000378:metabolism / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000494:pharmacology; D019943:Amino Acid Substitution; D000596:Amino Acids / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites / Q000235:genetics; D019556:COS Cells; D002522:Chlorocebus aethiops; D006224:Cricetinae; D000242:Cyclic AMP / Q000378:metabolism; D004082:Dihydroalprenolol / Q000378:metabolism / Q000494:pharmacology; D005998:Glycine / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D006860:Hydrogen Bonding; D007545:Isoproterenol / Q000378:metabolism / Q000494:pharmacology; D008958:Models, Molecular; D009154:Mutation; D011485:Protein Binding / Q000187:drug effects; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D011869:Radioligand Assay; D018343:Receptors, Adrenergic, beta-2 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000596:Amino Acids; D018343:Receptors, Adrenergic, beta-2; D012694:Serine; D004082:Dihydroalprenolol; D000242:Cyclic AMP; D007545:Isoproterenol; D005998:Glycine
Electrophoresis. 1997 Dec;18(15):2714-23
9504803
Science. 2010 Nov 19;330(6007):1066-71
20929726
J Biol Chem. 1997 Jul 25;272(30):18546-9
9228019
Mol Pharmacol. 2001 Jul;60(1):1-19
11408595
Science. 2007 Nov 23;318(5854):1258-65
17962520
Mol Pharmacol. 2009 Apr;75(4):982-90
19168624
Annu Rev Biophys. 2010;39:309-28
20192770
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5796-801
10823938
Protein Sci. 2010 Jan;19(1):85-93
19916165
J Biol Chem. 1994 Mar 4;269(9):6743-52
8120034
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4105-14
18487375
Mol Pharmacol. 2009 Jan;75(1):44-59
18923064
J Biol Chem. 2002 Oct 25;277(43):40989-96
12167654
EMBO J. 1997 Nov 17;16(22):6737-47
9362488
J Mol Biol. 2006 Mar 17;357(1):163-72
16414074
Protein Sci. 2006 Jun;15(6):1433-40
16731977
Biophys J. 2002 May;82(5):2720-36
11964258
J Mol Biol. 2004 Mar 26;337(3):713-29
15019789
Science. 2000 Aug 4;289(5480):739-45
10926528
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7027-32
17438264
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8874-8
2962193
J Biol Chem. 1988 Jul 25;263(21):10267-71
2899076
Nature. 1986 May 1-7;321(6065):75-9
3010132
Annu Rev Pharmacol Toxicol. 2006;46:481-519
16402913
J Mol Biol. 2004 Nov 5;343(5):1409-38
15491621
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14367-72
19706523
Proteins. 2004 Jul 1;56(1):67-84
15162487
Nat Chem Biol. 2005 Jul;1(2):98-103
16408006
J Biol Chem. 2010 Feb 5;285(6):3973-3985
19920139
J Biol Chem. 1989 Jun 5;264(16):9266-70
2542304
J Biol Chem. 1998 Apr 24;273(17):10445-53
9553103
J Mol Recognit. 1995 Nov-Dec;8(6):334-44
9052974
J Biol Chem. 2009 Apr 10;284(15):10190-201
19176531
Nat Rev Mol Cell Biol. 2003 Mar;4(3):181-91
12612637
J Biol Chem. 1996 Dec 13;271(50):32330-6
8943295